Free Trial

Medicxi Ventures Management (Jersey) Ltd Top Holdings and 13F Report (2026)

About Medicxi Ventures Management (Jersey) Ltd

Investment Activity

  • Medicxi Ventures Management (Jersey) Ltd has $981.81 million in total holdings as of March 31, 2026.
  • Medicxi Ventures Management (Jersey) Ltd owns shares of 4 different stocks, but just 1 company or ETF makes up 80% of its holdings.
  • About 10.28% of the portfolio was sold this quarter.
  • This quarter, Medicxi Ventures Management (Jersey) Ltd has purchased 5 new stocks and bought additional shares in 0 stocks.
  • Medicxi Ventures Management (Jersey) Ltd sold shares of 1 stock and completely divested from 1 stock this quarter.

Largest Holdings

Aura Biosciences
$20,336,877

Largest Sales this Quarter

NewAmsterdam Pharma
195,383 shares (about $6.25M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofMedicxi Ventures Management (Jersey) Ltd

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
$792,936,5960.0%19,963,15780.8%Medical
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
$85,600,566$6,254,210 -6.8%2,674,1828.7%Medical
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
$82,931,3950.0%7,464,5728.4%Medical
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$20,336,8770.0%3,039,8922.1%Medical
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
$0$94,632,780 -100.0%00.0%Medical

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data